FDA Approved: SUMATRIPTAN — Supplemental Application (Eugia US LLC)

View source ↗

Summary

FDA approved a supplemental application for Sumatriptan from Eugia US LLC under ANDA 202758.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Sumatriptan (Sumatriptan)

Snippet

SUPPL AP for SUMATRIPTAN (SUMATRIPTAN)